8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 6, 2006

Rochester Medical Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

Minnesota	0-18933	41-1613227
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
One Rochester Medical Drive, Stewartville, Minnesota		55976
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: 507-533-9600

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On November 6, 2006, Rochester Medical Corporation announced it had been awarded a national Group Purchasing Contract for urological products from Premier Purchasing Partners, L.P. The agreement becomes effective March 1, 2007. A copy of the press release that discusses these matters is filed as Exhibit 99.1 to, and incorporated by reference in, this report.

Item 9.01 Financial Statements and Exhibits.

99.1 Press release dated November 6, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Rochester Medical Corporation
November 7, 2006	By:	/s/ David A. Jonas
		Name: David A. Jonas
		Title: Chief Financial Officer

Exhibit Index

Exhibit No.	Description
99.1	Press Release dated 11-6-2006

EX-99.1

FOR RELEASE
November 6, 2006

Rochester Medical Corporation Awarded National Group Purchasing Contract For Urological
Products

Stewartville, MN November 6, 2006

Rochester Medical Corporation (NASDAQ:ROCM) today announced that group purchasing organization, Premier Purchasing Partners, L.P. (“Premier”) has awarded the Company a national contract for supplying Premier’s participating members with urological products, including Rochester Medical’s line of infection control catheters.

Premier is one of the largest Group Purchasing Organizations in the United States with over $27 billion in contract purchases per year. Its members include more than 1,500 hospital facilities and hundreds of other care sites.

The contract has a 27 month term from the effective date of March 1, 2007. Initial marketing efforts are expected to commence prior to that date. The contract includes Rochester Medical’s Foley Catheters (including its infection control catheters), Male External Catheters, Intermittent Catheters, and Urethral Inserts.

Commenting on the news, Company CEO and President Anthony J. Conway said, “I am very pleased to make this announcement. Rochester Medical products offer Premier’s member hospitals and other care facilities important new choices for advanced catheter technologies which provide unique benefits for their patients. We welcome this opportunity and look forward to working with Premier and with its membership to build a relationship of trust, value, and innovation that cost-effectively brings patients the benefits of the most advanced products in their classes.”

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications. The Company markets under its own Rochester Medical^® brand and under existing private label arrangements.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer of Rochester Medical Corporation at (507) 533-9600. More information about Rochester Medical is available on its website at http://www.rocm.com.